ERA Congress in Stockholm: FLOW Study, Dialysis Developments, and CKD Treatment
The European Renal Association (ERA) is hosting its 61st ERA Congress in Stockholm, Sweden, with a focus on “Rethinking kidney health, transforming kidney care.” This annual event is set to bring together over 6500 participants from 125 countries, with 250 speakers discussing topics ranging from chronic kidney disease (CKD) to advancements in dialysis and artificial intelligence.
One of the highly anticipated sessions will present key data from the FLOW Study, a groundbreaking trial showcasing positive kidney outcomes in patients with type 2 diabetes and CKD treated with GLP-1 receptor agonist semaglutide. This session marks a historic moment for the ERA Congress, as it is entirely dedicated to the results and implications of this trial. Experts believe that the findings from the FLOW Study could revolutionize clinical practices.
Late-breaking research will also include insights on GLP-1s, such as a secondary analysis of the SELECT trial and results from the APPEAR-C3G trial evaluating oral factor B inhibitor iptacopan. Additionally, new biomarkers for tracking kidney disease progression will be discussed, along with results from the FIDELITY trial evaluating hyperkalemia risk and the effects of finerenone.
Kidney Disease: A Global Public Health Emergency
ERA Congress aims to address the global impact of kidney disease through sessions like “CKD as a Global Health Issue: A Call to Action.” The importance of prevention, early detection, and intervention will be emphasized, with CME courses covering topics like bone mineral disorders in CKD and novel techniques for assessing vascular calcification.
A focus on kidney transplantation will feature discussions on referring various patient populations, including the elderly, obese, nonadherent, and those with cardiovascular disease. Experts will debate topics like “Treatment of obesity in diabetic kidney disease” and “Should we still collect 24h urine to follow-up kidney stone formers?” in a PRO-CON format.
Resonant Insights and Experiences for Clinicians
Leading international experts will deliver compelling plenaries on topics like “Finding solutions for human life in the natural world,” “Can we extend kidney health span?,” and “Novel bio-inspired therapeutic strategies for kidney disease.” The congress aims to provide valuable insights and experiences to enhance clinicians’ practices and outlooks, fostering collaborations and friendships among attendees worldwide.
In conclusion, the 61st ERA Congress promises to be a transformative event, bringing together experts from around the globe to discuss the latest advancements in nephrology and shape the future of kidney care.